Leachable Risk Assessment: A structured approach to meet regulatory expectations

Led by representatives from Smithers Rapra and GlaxoSmithKline, this year's workshop is designed to give practical experience of performing a technical risk assessment to evaluate exposure risk to patients from leachables derived from container closure or manufacturing materials.

The workshop will consist of a mixture of short presentations and predominantly an interactive element in performing a risk assessment on a fictitious medical product.

The workshop will run for the full day on Tuesday May 9 and tickets are $899 in addition to your 2-day conference ticket. Places are limited (and subject to approval) so we advise booking as soon as possible to avoid missing out!